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Abstract
Background: Organotin compounds (OTCs) have been widely used as stabilizers in the production of plastic, 
agricultural pesticides, antifoulant plaints and wood preservation. The toxicity of triphenyltin (TPT) compounds was 
known for their embryotoxic, neurotoxic, genotoxic and immunotoxic effects in mammals. The carcinogenicity of TPT 
was not well understood and few studies had discussed the effects of OTCs on gap junctional intercellular 
communication (GJIC) of cells.
Method: In the present study, the effects of triphenyltin chloride (TPTC) on GJIC in WB-F344 rat liver epithelial cells 
were evaluated, using the scrape-loading dye transfer technique.
Results: TPTC inhibited GJIC after a 30-min exposure in a concentration- and time-dependent manner. Pre-incubation 
of cells with the protein kinase C (PKC) inhibitor did not modify the response, but the specific MEK 1 inhibitor PD98059 
and PI3K inhibitor LY294002 decreased substantially the inhibition of GJIC by TPTC. After WB-F344 cells were exposed 
to TPTC, phosphorylation of Cx43 increased as seen in Western blot analysis.
Conclusions: These results show that TPTC inhibits GJIC in WB-F344 rat liver epithelial cells by altering the Cx43 protein 
expression through both MAPK and PI3-kinase pathways.
Background
Organotin compounds have been widely used as agricul-
tural biocides, antifouling agents in boat paint, wood pre-
servatives, and stabilizers for polyvinylchloride polymers
(PVC) in industry [1,2]. Triphenyltin (TPT) is an organo-
tin compound which is widely used as fungicides on
major food and food-stock crops. It is also used in anti-
fouling paints to prevent growth of barnacles and other
fouling organisms on boats and ships [3]. Organotin com-
pounds are known to be endocrine disruptors in marine
species and may be mahuman beings [4,5]. Tissue con-
centrations of TPT were correlated with the degree of
imposex in rock shells [6,7]. TPT compounds have
embryotoxic, myotoxic, genotoxic and immunotoxic
effects in mammals [8-11]. The organotin compounds
might be incorporated in the most abundant phospho-
lipid of eukaryotic membrane and caused toxicity [12].
Some toxic effects have been observed in aquatic and ter-
restrial organisms exposed to TPT, such as increased
tumor incidence and immune suppression [13,14]. Some
studies have revealed that TPT might inhibit the cyto-
toxic function of human natural killer cells and triphenyl-
tin hydroxide produced tumors in rats and mice [14-16].
Connexins (Cxs) are a group of at least 20 highly con-
served proteins that provide the basis for communication
through the direct exchange of ions, nutrients, second
messengers, electrical coupling, and small metabolites
from one cell to its neighboring cells [17-20]. Cell prolif-
eration, differentiation, apoptosis and adaptive responses
of differentiated cells can occur as a consequence of the
up- or down-regulation of GJIC [21-23]. Disruption in
GJIC may cause loss of homeostatic and cell growth con-
trol [18,24-26]. Growing evidence suggests that connexin
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43 (Cx43), a major gap junction protein, functions as a
tumor suppressor gene. Expression of Cx43 is often
decreased in human tumor cells and tissues, including
those involved in human mammary carcinoma, prostate
cancer, human glioblastoma, skin squamous cell carci-
noma, lung cancer, esophagus cancer, adrenocortical
tumors, ovarian carcinoma, cervical cancer, endometrial
carcinoma, and human mesothelioma [27-37]. It has been
assumed that using pharmacological stimulation to effi-
ciently restore GJIC in tumor cells might represent a
strategy for anti-neoplastic therapies [38-42].
The carcinogenicity of TPT remained unclear. The
present work was undertaken to define the effects of
TPTC on GJIC in WB-F344 rat liver epithelial cells.
Materials and methods
Chemicals
Powder of TPTC was supplied by MERCK (Darmstadt,
Germany).
Lucifer yellow, DMSO (dimethylsulfoxide), formalde-
hyde, MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-
2H-tetrazolium bromide) were supplied by Sigma-
Aldrich (St. Louis, MO, USA). D medium and newborn
calf serum were from Gibco (Invitrogen cooperation, CA,
USA), Trizole was from Invitrogen Life Technologies
(Rockville, MD, USA) and 2 X SYBR green PCR master
mix was from Applied Biosystems (Foster, CA, USA). The
protein kinase C (PKC) inhibitor GF109203X, extracellu-
lar signal-regulated protein kinase (ERK) inhibitor
PD98059 and PI3 kinase inhibitor LY294002 were from
Sigma (St. Louis, MO, USA). Immobilon Western HRP
Substrate Peroxide Solution and luminal reagent were
supplied by Millipore Corporation (Billerica, MA). All
chemicals used in the study were of the highest available
purity.
Cell culture and treatment with chemicals
WB-F344 rat liver epithelial cells [43] were cultured in D
medium supplemented with 5% fetal bovine serum and
1% [v/v] penicillin/streptomycin antibiotic. The cells
were grown at 37°C in a 5% CO2 incubator before being
used in the different experiments. Confluent cells, grown
in plates, were exposed to various concentrations of
TPTC. To prepare the TPTC stock solution, 0.01 g of
TPTC powder was dissolved in 10 ml DMSO and then
diluted to a final concentration of 1000 ppm.
Cell toxicity assay of TPTC
The effect of TPTC on the survival of WB F344 cells was
assessed using MTT toxicity assay as described previ-
ously [44]. In brief, the cells were plated in 100 μl media
in 48-well plates (1 × 104/well). On the following day, the
experimental medium containing different TPTC con-
centrations (0, 0.25, 0.5, 1, 2, 3, 4, and 5 ppm) was added,
and then incubated for 30 and 60 minutes. Fifty μl of
MTT solution (2 mg/ml in PBS) was added to each well
and incubated for 6-8 hours. After careful removal of the
medium, 150 μl of DMSO was added to each well, and
then after careful shaking, the absorbance was read at 570
nm using an ELISA microplate reader (Zenyth 200rt with
ADAP software, Anthos Labtec Instruments, Autria).
Cell viability was expressed as a percentage of control
cells not treated with TPTC and was designated as 100%.
Colony forming-efficiency assay
Colony forming-efficiency experiments were performed
as previously described [45]. In brief, exponentially grow-
ing cells were plated at 500 cells/100 mm tissue culture
dish in 10 ml D medium, treated with different concen-
trations of TPTC. Following treatment, the plates were
washed two times with the medium. The medium was
not replaced, and colonies were fixed and stained after 14
days in culture by water: addition of methanol (1:1) con-
taining crystal violet (1 g/l). Colonies with cell clusters
containing more than 50 cells were counted under a dis-
secting microscope. Data indicate survival as a percent-
age relative to untreated cells.
GJIC inhibition assay
GJIC assay was carried out in 35 × 10 mm tissue culture
dishes with 100% confluent monolayer cells grown in 2
ml D-medium supplemented with 5% newborn calf
serum, 100 U/ml penicillin and streptomycin 100 μg/ml.
GJIC was detected using the scrape-loading and dye
transfer (SL/DT) technique developed by el-Flouly [46].
Assays for different treatments and vehicle control were
run in triplicate in cell culture dishes. Monolayer cells
with 100% confluence were incubated with target com-
pounds. For dose-dependent inhibition of GJIC, we
treated cells with 0.5, 1.0, 1.5 and, 2.0 ppm TPTC for 30
min. For time-dependent inhibition of GJIC, analysis was
performed with 1.5 ppm TPTC for 15, 30, 45, and 60 min.
After exposure to the target compounds, the cells were
rinsed three times with PBS and 1 ml of lucifer yellow
solution was then added to the cell cultures and scrape-
loaded with several scrapes using a steel surgical blade.
The dye solution was left on the cell cultures for 3 min,
and then discarded. The cell cultures were carefully
rinsed three times with PBS to remove detached cells and
background fluorescence. Several drops of 4% formalin in
PBS were added to fix the cell cultures. An inverted fluo-
rescence microscope equipped with a digital camera
(Nikon Eclipse TE 2000-U system, Nikon ACT-1 version
2.62, Nikon Corporation, Japan) was employed to record
the migration of the lucifer yellow dye from the edge cells
of the scrape. The migration was measured on the micro-
graph. An average value of 30 measurements for each
treatment (10 measurements per dish) was regarded asLee et al. Journal of Occupational Medicine and Toxicology 2010, 5:17
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the migration of dye in the cell cultures. The percentage
of migration of dye in cell cultures exposed to target com-
pounds to the migration of dye traveling in the vehicle
control was employed to evaluate the inhibition of GJIC.
For inhibition studies, cultures were pre-incubated for 30
min with various pathway inhibitors prior to treatment
with 1.5 ppm TPTC for 30 min.
Western blot analysis
WB F344 liver cells were treated with TPTC of 1.5 ppm
for 15 and 30 min. After treatment, the medium was
removed and cells were washed twice with PBS and lysed
with 0.5% SDS. Lysates were stored at -80°C. Cell lysates
were sonicated, and protein levels were determined using
a protein detection assay (BioRad). Sample blue buffer
(30% sucrose, 10% SDS, 0.1% bromophenol blue, and
0.2% dithiothreitol) was added and the samples were
heated for 10 min at 100°C and loaded onto gels (10%
SDS-PAGE). SDS-PAGE-separated proteins were blotted
onto a PVDF membrane (Immobilon-PSQ, Millipore,
Bedford, MA) using a semi-dry blotter (VWR), and the
m e m b r a n e  was  b l oc k ed  wi t h  5 %  m i l k  i n  P BS- T  b u f f e r
[1000 ml PBS with 1 ml Tween 20 (pH 7.4)] for more than
1 h at room temperature. The protein was probed with
antibodies (Mouse IgG, Zymed) against connexin 43 at
4°C overnight and this was followed by incubation with
horseradish peroxidase-conjugated secondary antibodies
(Mouse anti-Goat IgG-HRP, Sigma). Protein visualization
was carried out using an enhanced chemiluminescence
kit (Pierce) according to the manufacturer's protocol.
Immunofluorescence staining
Immunofluorescence staining experiment s were per-
formed as previously described[47]. In brief, WB F344
liver cells were plated in 100 μl media in 12 well-plates
treated with 1.5 ppm TPTC for 30 min. After treatment,
the medium was removed and sections were washed with
PBS. 4% paraformaldehyde was added and washed sec-
tions with PBS 20 min later. 0.5% triton X-100 (Sigma)
was added for 20 min and washed out with PBS. After
treatment, diluted primary antibodies mouse IgG against
connexin 43 (Santa Cruz Biotechnology, Inc.) with 4% tri-
ton X-100 was added and incubated sections for 1 h at
room temperature. The sections were washed with PBS,
and diluted mouse IgG secondary antibody (Alexa
Fluor555 &488) with 4% triton X-100 was added and
incubated sections for 1 h at room temperature. After
treatment, 4,6'-diamidino-2-phenylindole (DAPI)(Sigma)
was added and incubated sections for 10 min at room
temperature. An inverted fluorescence microscope
equipped with a digital camera (Nikon Eclipse TE 2000-U
system, Nikon ACT-1 version 2.62, Nikon Corporation,
Japan) was employed to record the fluorescent intensity
of the cells.
Statistical analysis
Means ± SEM were calculated and the data are presented
a s  a  p e r c e n t a g e  o f  c o n t r o l .  A l l  d a t a  w e r e  a n a l y z e d  b y
Sigma Plot 8.0 software using repeated measures.
ANOVA (SPSS for window version 12.0.1; SPSS, Inc.,
Chicago, IL) was performed to examine the effect of inde-
pendent variables (treatment, day, incubation time, time
point). Tests for contrasts were carried out to compare
the different levels of the independent variables. P values
≤ 0.05 were considered statistically significant.
Results
TPTC dissolved easily in DMSO but not in water. To
exclude the toxic effects of DMSO on cell viability and
diffusion length of GJIC, tests involving exposure to
DMSO were carried out. Results revealed that after expo-
sure to 2% DMSO for 30 minutes, the diffusion length of
GJIC did not obviously decrease as compared with that of
the control group (p > 0.05).
Cytotoxicity of TPTC
Cytotoxicity evoked by TPTC in WB-F 344 cells was
tested with 0, 0.25, 0.5, 1, 2, 3, 4, and 5 ppm of TPTC
using the MTT proliferation assay. After 30- and 60-min
exposure to TPTC, it was found that cell viability
decreased obviously with increasing concentration of
TPTC and the lethal concentration 50 (LC 50) in 60 min
calculated was 5 ppm (Fig. 1A.)
Colony-forming efficiency in WB-F 344 cells was evalu-
ated using TPTC of 0, 3, 9, 12, 15, 18 ppb. After 14 days of
exposure, the colony-forming efficiency decreased signif-
icantly when TPTC concentration exceeded 12 ppb (Fig.
1B.)
Dose- and time- dependent inhibition of GJIC by TPTC
Inhibition of GJIC has been suggested to be an important
activity of tumor promoters [36]. Therefore, the capacity
of TPTC to inhibit GJIC was measured in concentrations
with 0.5, 1.0, 1.5 and 2 ppm TPTC after 30 min of expo-
sure. As shown in Figure 2A, TPTC inhibited significantly
GJIC in WB-F344 liver cells. The migration of Lucifer yel-
low dye in scraped WB F344 liver cells treated with TPTC
was less than that in untreated cells, when the concentra-
tion was 1.0 ppm (*p < 0.05).
The effects of TPTC on GJIC were evaluated with cells
exposed to TPTC for 15 min, 30 min, 45 min, and 60 min.
After 15 min of exposure to 1.5 ppm of TPTC, the diffu-
sion length was significantly decreased as compared with
that of the control group (p < 0.05) (Fig. 2B). The diffu-
sion length reduced gradually with time and becameLee et al. Journal of Occupational Medicine and Toxicology 2010, 5:17
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almost invisible after 60 min of exposure to 1.5 ppm of
TPTC.
Effects of PKC, ERK and PI3 kinase on GJIC response
Organotin compounds showed that inhibition through
some kinase pathways is a possible mechanism involved
in the apoptotic effects [48]. The mitogen-activated pro-
tein kinase (MAPK) pathway has been shown to be
involved in the inhibition of GJIC by TPA [49-54]. Its role
in the TPTC-induced inhibition of GJIC was studied
next. No specific inhibitor of MAPK was available, but
PD98059, a MEK1 inhibitor that blocks ERK activation,
was used as an inhibitor of the pathway [55-57]. MEK 1 is
the direct upstream activator kinase of MAPKs. The cells
were pre-exposed to 50 μM PD98059 for 30 min prior to
co-exposure to TPTC (1.5 ppm) for 30 min The scrape-
loading assays were then repeated using the ERK inhibi-
tor PD98059. The data showed that PD98059 restored
significantly GJIC in TPTC-treated liver cells (p < 0.05)
(Fig. 3), Thus, the MAPK signaling pathway was clearly
involved in the inhibition of GJIC by TPTC.
Phosphatidylinositol 3'-kinase (PI3K) has been demon-
strated to be critical in mediating several aspects of
PDGF actions in various cells [23,58-62]. To explore the
potential role of PI3K signaling in the signaling processes
involved in TPTC-induced disruption of GJIC in liver
cells, we measured GJIC in rat liver cells with and without
pre-treatment with the Pl3K inhibitor LY294002 (100
μmol/L) before exposure to TPTC (1.5 ppm) for 30 min.
As shown in Fig. 4, pre-incubation of rat liver cells with
LY294002 (100 μmol/L) for 30 min almost stopped com-
pletely the inhibition of GJIC caused by TPTC, although
the inhibitor itself did not exert much influence on GJIC,
as compared with the control. Similar result was also
found in the group exposed to TPTC and PD98059 as
compared with that exposed to TPTC alone (Fig. 3).
Thus, we conclude that TPTC blocked GJIC through
MAPK and PI3K pathways.
To study the involvement of protein kinase C (PKC) in
the inhibition of GJIC by TPTC, an inhibitor of PKC,
GF109203X (bisindolylmaleimide 1) was utilized to block
the activity of the enzyme before exposure to TPTC-
GF109203X inhibits the isozymes of PKC α, βI, βII, γ, δ,
and ε [63,64]. The cells were pre-exposed to the PKC
inhibitor (10 μM) for 30 min prior to co-exposure to
TPTC (1.5 ppm) and incubated further for 30 min. The
diffusion length of GJIC did not obviously decrease when
only GF109203X was added. On the other hand, cells
were treated with 10 μM GF109203X for 30 min, followed
by addition of TPTC. The diffusion length of GJIC
decreased obviously following the addition of TPTC or
TPTC with GF109203X (Fig. 5)., No change was observed
in the inhibition of GJIC by TPTC alone. Thus, the inhi-
bition of GJIC by TPTC was not mediated by PKC.
Neither GF109203X, LY294002 nor PD98059 alone at
the indicated concentration had any notable effects on
GJIC in these cells.
Effects of TPTC on connexin 43 protein level and 
phosphorylation
One possible mechanism involved in the inhibition of
GJIC is abnormal phosphorylation of connexins [65-67].
WB-F433 cells express Cx43 predominantly as gap junc-
tion protein [68]. Western blot analysis was performed to
detect the state of Cx43 phosphorylation in WB-F344
cells after treatment with TPTC. In untreated cells, three
Figure 1 Cytotoxicity of TPTC in WB-F344 liver cell. (A) Cell viability of WB-F344 liver cells after exposure to TPTC of different concentrations for 30 
min and 60 min. LC50 of TPTC in WB-F344 liver cells amounted to 5 ± 0.9 ppm, n = 5. (B) Colony-forming efficiency of WB-F344 cells treated with dif-
ferent concentrations of TPTC. When the concentration of TPTC was 12 ppb, the proliferation of WB-F344 liver cells was significantly inhibited. Data 
indicate survival as a percentage relative to untreated cells. All values are represented as means ± S.D. of five independent experiments. Statistical 
significance was determined using ANOVA (*p < 0.05).Lee et al. Journal of Occupational Medicine and Toxicology 2010, 5:17
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isoforms of Cx43, which correspond to different phos-
phorylated forms of Cx43, are detectable as P0 (unphos-
phorylated form), P1 and P2 (phosphorylated forms),
respectively [69]. After 15-min and 30-min exposure to
TPTC, the P0 band disappeared, and a shift to bands of
higher molecular weight occurred (P1) (Fig. 6).
Effects of TPTC on connexin 43 in immunofluorescence 
staining
The expression of Cx43 in WB-F344 cell under stained
with fluorescein isothiocyanate (FITC) and DAPI after
30-min exposure with1.5 ppm TPTC compared to the
control group (A) with 1.5% DMSO was showed (Fig. 7).
The fluorescent intensity did decrease in group (B) after
exposure with TPTC.
Discussion
Carcinogenesis is a multistep process, including "initia-
tion," "promotion," and "metastasis" ("progression") [70].
Potter suggested that the initiation process prevents
genetically altered stem cells from terminally differentiat-
ing [71], and, at the same time, GJIC restricts the growth
of these cells. However, when exposed to tumor promot-
ers, which inhibit GJIC, these transformed cells prolifer-
ate [37]. The results of this study indicate that the TPTC
inhibits GJIC in WB-F344 rat liver epithelial cells in a
concentration- and time-dependent manner. In the pres-
ent study, we demonstrate for the first time that exposure
TPTC results in downregulation of Cx43 expression in
liver cell cultures. Moreover, we show that TPTC modu-
lates Cx expression predominantly through activation of
MAPK and PI3K signaling pathways. Several in vivo and
in vitro studies have revealed potential effects of organo-
tins in broad spectrum including immunosuppressive,
neurotoxic, endocrinopathic, reproductive, teratogenic,
developmental, and possibly carcinogenic activity
[3,13,72-75]. Alterations in the phosphorylation status of
Figure 2 Inhibition of GJIC by TPTC using the modified scrape-loading/dye transfer method with the Lucifer yellow fluorescent dye. (A) 
Dose-dependent inhibition of GJIC after 30-min TPTC exposure. (B) Time-dependent inhibition of GJIC exposed to TPTC. Cells were treated with 1.5 
ppm TPTC. The results are represented as means ± S.D. of at least three independent experiments. Statistical significance was determined using ANO-
VA (*p < 0.05).
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connexins are a consequence of the activities of the pro-
tein kinase and/or protein phosphatases. GJIC recovered
when pre-treated with PD 98059 (ERK inhibitor), and
LY294002 (PI3-kinase inhibitor), but did not recover
when GF109203X (Protein Kinase C inhibitor) was
added. The reactions of fluorescence of Cx43 in WB-
F344 cells after treatment with TPTC did decrease and
the phosphorylation of Cx43 was found in Western Blot
analysis. Some studies also showed that TPTC could
inhibit the phosphorylation and ATP formation in chlo-
roplasts and embryos of marine invertebrate [9,76].
The inhibition of GJIC by TPTC was independent of
PKC activity but clearly dependent upon the activation of
both MAPK and PI3-kinase pathways. The loss of GJIC
Figure 3 Effect of PD98059 (MEK 1 inhibitor) on TPTC-induced 
disruption of GJIC in WB-F344 cells (mean values ± S.D.). The con-
trol group comprises negative controls. The PD98059 group comprises 
cells treated with 50 μM PD98059 for 30 min. The TPTC group compris-
es cells treated with 1.5 ppm TPTC for 30 min. The PD98059 + TPTC 
group comprises cells pre-treated with 50 μM PD98059 for 30 min and 
then exposed to 1.5 ppm TPTC for 30 min. Asterisks indicate statistically 
significant difference. (# p < 0.05 compared with the control group, *p 
< 0.05 compared with the group exposed to PD98059 alone, and &p < 
0.05 compared with the group exposed to TPTC alone.)
 
 
 
                   
PD 98059 PD 98059+ TPTC
Figure 4 Effect of LY294002 (PI3K inhibitor) on TPTC-induced dis-
ruption of GJIC in WB-F344 cells (mean values ± S.D.). The control 
group comprises negative controls. The LY294002 group comprises 
cells treated with.100 μM LY294002 for 30 min. The TPTC group com-
prises cells treated with 1.5 ppm TPTC for 30 min. The LY294002 + TPTC 
group comprises cells pre-treated with 100 μM LY294002 and exposed 
to 1.5 ppm TPTC for 30 min. Asterisks indicate statistically significant 
difference. (# p < 0.05 compared with the control group, * p < 0.05 
compared with the group exposed to LY294002 alone, and p < 0.05 
compared with the group exposed to TPTC alone.)
Figure 5 Effect of GF109302X (PKC inhibitor) on TPTC-induced 
disruption of GJIC in WB-F344 cells (mean values ± S.D.). The con-
trol group comprises negative controls. The GF109302X group com-
prises cells treated with 10 μM GF109203X for 30 min. The TPTC group 
comprises cells treated with 1.5 ppm TPTC for 30 min. The GF109302X 
+ TPTC group comprises cells pre-treated with 10 μM GF109203X for 
30 min and then exposed to 1.5 ppm TPTC for 30 min. Asterisks indi-
cate statistically significant difference. (# p < 0.05 compared with the 
control group, *p < 0.05 compared with the group exposed to 
GF109302X alone.)
 
Figure 6 Western blot analysis of Cx43, α-tublin, and E-cadherin 
protein expression alterations in TPTC treated WB F344 liver cells. 
A: T, TPTC 1.5 ppm (15-min exposure); D, negative control (DMSO). B: T, 
TPTC 1.5 ppm (30-min exposure); D, negative control (DMSO). P0 grad-
ually decreased and density of P1 increased. The band of P0 totally dis-
appeared after exposure to 1.5 ppm TPTC for 30 min. No change of α-
tublin, and E-cadherin protein were found. MW: Connexin 43 was 43 
kD, α-Tublin was 55 kD, and E-Cadherin was 120 kD.
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was also described in cancer cells [77,78]. Alteration in
expression of connexins may be involved in the expres-
sion of neoplastic phenotype [79] and changes in the
phosphorylation pattern of connexins are also associated
with GJIC inhibition by other tumor-promoting agents
and oncogenes [80-82].
Hence, there is no evidence of a causal cross-talk
between the two modulatory pathways, MAPK and PI3K.
However, both PD58059 and LY294002 abolished com-
pletely the effect of TPTC downregulation of Cx43, impli-
cating both MAPK and PI3K signaling cascades in a
common mechanism of Cx regulation. It is possible that
MAPK and PI3K act through a common downstream
pathway, such as GSK-3 activation [83-86], to control
endothelial cellular function through Cxs.
In conclusion, the present study shows that TPTC
inhibits GJIC in WB-F344 rat liver epithelial cells by
altering the Cx43 protein expression through the MAPK
Figure 7 The expression of Cx43 in WB-F344 cell under stained with FITC and DAPI. A. expression of Cx43 in WB-F344 cell with 1.5% DMSO; B: 
expression of Cx43 in WB-F344 with 1.5 ppm TPTC after 30-min exposure. The fluorescent intensity did decrease in FITC stain after treatment with 1.5 
ppm of TPTC for 30 min.
AP h a s e BP h a s e
A FITC
A FITC&DAPI
B FITC
B FITC&DAPILee et al. Journal of Occupational Medicine and Toxicology 2010, 5:17
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and PI3-kinase pathways. However, to prove the carcino-
genicity of TPTC still needs further study. This prelimi-
nary study could provide the possible mechanism for
further evaluation of toxicity of TPTC.
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